Managers / Q2 2023 · view latest →
Yong Rong (HK) Asset Management Ltd
CIK 0001738071 · UNIT 1702, 17/F, INFINITUS PLAZA, 199 DES VOEUX ROAD CENTRAL, SHEUNG WAN, K3, 000000 · 85236203247
Summary
Yong Rong (Hk) Asset Management Ltd reported $228M in U.S.-listed holdings across 21 positions for Q2 2023.
The portfolio is heavily concentrated: PLTR alone accounts for 25.4% of reported value.
Compared with Q1 2023, the fund opened 14 new positions and exited 9.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 85.8% · $196M
- ETP · 10.4% · $24M
- Other · 1.9% · $4M
- ADR · 1.9% · $4M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| PLTRPALANTIR TECHNOLOGIES INC | NEW | +3.78M | 3.78M | +$58M | $58M |
| MDBMONGODB INC | NEW | +131.8K | 131.8K | +$54M | $54M |
| METAFACEBOOK INC | NEW | +125.0K | 125.0K | +$36M | $36M |
| TQQQPROSHARES TR | NEW | +571.0K | 571.0K | +$23M | $23M |
| SDGRSCHRODINGER INC | NEW | +357.2K | 357.2K | +$18M | $18M |
| RXRXRECURSION PHARMACEUTICALS IN | NEW | +1.17M | 1.17M | +$9M | $9M |
| ISPRISPIRE TECHNOLOGY INC | NEW | +875.0K | 875.0K | +$8M | $8M |
| MUMICRON TECHNOLOGY INC | NEW | +100.0K | 100.0K | +$6M | $6M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | PLTRPALANTIR TECHNOLOGIES INChistory → | CL A | 25.44% | $58M | 3.78M |
| 2 | MDBMONGODB INChistory → | CL A | 23.76% | $54M | 131.8K |
| 3 | METAFACEBOOK INChistory → | CL A | 15.73% | $36M | 125.0K |
| 4 | TQQQPROSHARES TRhistory → | ULTRAPRO QQQ | 10.27% | $23M | 571.0K |
| 5 | SDGRSCHRODINGER INChistory → | COM | 7.82% | $18M | 357.2K |
| 6 | RXRXRECURSION PHARMACEUTICALS INhistory → | CL A | 3.85% | $9M | 1.17M |
| 7 | ISPRISPIRE TECHNOLOGY INChistory → | COM | 3.50% | $8M | 875.0K |
| 8 | MUMICRON TECHNOLOGY INChistory → | COM | 2.77% | $6M | 100.0K |
| 9 | MRVLMARVELL TECHNOLOGY INChistory → | COM | 2.66% | $6M | 101.6K |
| 10 | RLXRLX TECHNOLOGY INChistory → | SPONSORED ADS | 1.16% | $3M | 1.50M |
| 11 | YATSEN HLDG LTD | ADS | 0.89% | $2M | 2.00M |
| 12 | REREATRENEW INC | SPONSORED ADS | 0.64% | $1M | 500.0K |
| 13 | LUFAX HOLDING LTD | ADS REP SHS CL A | 0.63% | $1M | 1.00M |
| 14 | ORCLORACLE CORP | COM | 0.17% | $382,000 | 3.2K |
| 15 | GENETRON HLDGS LTD | ADS | 0.13% | $300,000 | 322.1K |
| 16 | DIREXION SHS ETF TR | SP BIOTCH BL NEW | 0.11% | $260,000 | 43.8K |
| 17 | VALENS SEMICONDUCTOR LTD | ORDINARY SHARES | 0.09% | $209,000 | 82.3K |
| 18 | INTCINTEL CORP | COM | 0.09% | $206,000 | 6.1K |
| 19 | TSMTAIWAN SEMICONDUCTOR MFG LTD | SPONSORED ADS | 0.06% | $132,000 | 1.3K |
| 20 | LKNCYLUCKIN COFFEE INC | SPONSORED ADS | 0.03% | $68,000 | 3.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $227M | 10 | May 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $330M | 23 | Jan 30, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $488M | 21 | Nov 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $415M | 18 | Aug 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $430M | 26 | Apr 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $231M | 24 | Feb 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $346M | 23 | Oct 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $291M | 17 | Jul 26, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $376M | 20 | May 2, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $266M | 16 | Feb 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $109M | 14 | Oct 19, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $228M | 21 | Jul 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $178M | 16 | Apr 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 15 | Jan 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $31M | 8 | Oct 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $128M | 18 | Jul 26, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $71M | 7 | May 4, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $127M | 16 | Feb 8, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $153M | 14 | Oct 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $402M | 18 | Aug 3, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $365M | 15 | May 6, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $371M | 16 | Feb 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $147M | 10 | Nov 3, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $114M | 14 | Aug 4, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $61M | 14 | Apr 28, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $75M | 14 | Feb 19, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $82M | 13 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $69M | 19 | Aug 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $325M | 25 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $148M | 18 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.